Our Stocks to Watch today include Sunrise Consulting Group, Inc. (OTC: SNRS), Oregon Pacific Bancorp (OTCBB: OPBP), Black Dragon Resource Companies, Inc. (OTC: BDGR), Millennium Cell Inc. (NASD: MCEL), PhytoMedical Technologies, Inc. (OTCBB: PYTO)
Visit http://www.otcpicks.com/ to register for our Daily Market Mover’s Digest Newsletter, and Email Stock Watch Alerts.
SUNRISE CONSULTING (OTC: SNRS)
"Up 233.33% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SNRS.php
Sunrise Consulting Group, Inc. CEO Raymond Chin, has been based in Hong Kong for the last 10 years and has established relationships with Chinese Companies that would like to go public and be listed on US exchanges such as (OTC.PK, OTC.BB, NASDAQ, AMEX, & NYSE). These companies are mostly from mainland China and Hong Kong, with contacts also in Laos, Vietnam, Malaysia, Australia and others in the Pacific Rim & Southeast Asia. The company's goal is to become the premier Investment Banking Firm servicing small to medium sized companies in China and throughout Asia. Management has had success with consulting with public companies in the United States as well.
SNRS News:
January 3 - Sunrise Consulting Group, Inc. Signs Letter of Intent With Cao Tian Iron Ore Mines, Hunan Province, China
Sunrise Consulting Group, Inc. (OTC: SNRS), signed a Letter of Intent with Cao Tian Iron Ore Mines, ZhuZhou City, Hunan Province, PRC "CHINA" for the concession rights to mine this particular area of that region for at least 30 years. The letter sets forth the basic terms and conditions under which both parties have agreed to.
Sunrise Consulting Group, Inc. will issue 1 million shares of preferred stock to own 100% of the mining rights when signing the final agreement. These shares will have guaranteed buyback options within 24 months at $1.00 USD per share. Total buyback will be $1,000,000 USD.
This particular parcel of land stretches to an astounding 3 square miles and the mountain has an estimated 3 million tons of Iron Ore that can be mined over the next 30 years. The company plans to rapidly move forward in accordance with terms and conditions set forth in the proposed agreement (LOI).
OREGON PACIFIC BANCORP (OTCBB: OPBP)
"Up 29.83% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/OPBP.php
Oregon Pacific Bancorp operates as the holding company for Oregon Pacific Banking Co., which provides various banking products and services to commercial enterprises, governmental entities, and individuals in Lane, Douglas, and Coos counties, as well as on the central Oregon coast. The company offers various consumer deposit products, including noninterest bearing checking accounts, interest bearing checking and savings accounts, money market accounts, and certificates of deposit. It provides consumer loans, such as secured and unsecured personal loans, home equity loans, personal lines of credit, and motor vehicle loans; real estate construction loans; residential mortgage loans; and commercial loans. Further, the company offers trust and asset management services, investment services, brokerage services, online banking services, banking on call, automated teller machines, debit cards, safe deposit boxes, letters of credit, travelers' checks, direct deposit of payroll, social security, dividend payments, and automatic payment of insurance premiums and mortgage loans. As of December 31, 2006, Oregon Pacific Bancorp operated through its main office and a full-service Safeway store branch in Florence, as well as two branches in Roseburg and Coos Bay, Oregon. The company was founded in 1979 and is headquartered in Florence, Oregon.
OPBP News:
January 2 - Oregon Pacific Bancorp Announces Reverse Stock Split and Plan to De-register
Oregon Pacific Bancorp (OTCBB: OPBP) (the "Company") announced that its Board of Directors has approved a plan to de-register the Company's common stock under the Securities Exchange Act of 1934, as amended, and, therefore, terminate its obligations to file reports with the Securities and Exchange Commission. This transaction would be accomplished through a reverse stock split of common shares of 1 for 500. All stockholders with less than one share after the reverse-split will have their partial shares cashed out at a price of $13.00 per pre-split share. Following the buyback of the partial shares, stock will split at 500 for 1. Shares of common stock held by shareholders owning more than 500 shares before the reverse split will remain outstanding and will be unaffected by the two transactions. The date for determining which shareholders shall be cashed out is January 4, 2008.
If, after completion of the transaction, Oregon Pacific Bancorp has fewer than 300 stockholders of record, the Company intends to terminate the registration of its common stock under the Securities and Exchange Act of 1934, as amended, and become a non-reporting company. If that occurs, the Company will no longer file periodic reports with the Securities and Exchange Commission ("SEC"), including annual reports on Form 10-K and quarterly reports on Form 10-Q, and will no longer be subject to the SEC's proxy rules.
The Board of Directors received a fairness opinion from an independent appraisal firm, Southard Financial, that the price of $13.00 per share cash out price to be paid to shareholders owning less than 500 shares is fair, from a financial point of view, to Company stockholders. The proposed transaction is subject to approval by the holders of a majority of the issued and outstanding shares of the Company's common stock. Stockholders will be asked to approve the transaction at a special meeting of stockholders, currently expected to be held in March 2008.
The proposed plan should result in a direct cost savings to Oregon Pacific in the near term from the elimination of SEC reporting requirements. Also, this plan will allow Oregon Pacific to avoid the substantial additional costs associated with the compliance and auditing requirements of the Sarbanes-Oxley Act of 2002, Section 404 ("SOX 404"). "We anticipate that the reduced burden on management will allow our officers the opportunity to be more responsive to the needs of their clients and the communities they serve," stated CEO James P. Clark. "By remaining a progressive, independent, community bank we can best serve our employees, stockholders and customers."
The Company has filed a preliminary proxy statement and Schedule 13E-3 with the SEC outlining the transaction. All stockholders are advised to read the definitive proxy statement and Schedule 13E-3 carefully when these documents are available. Stockholders may obtain a free copy of the proxy statement and Schedule 13E-3 at the SEC's web site at http://www.sec.gov/. Oregon Pacific Bancorp will also mail a copy of the definitive proxy statement prior to the special meeting to its stockholders entitled to vote at the special meeting.
For more information about the above transaction, contact Joanne Forsberg, Secretary, at (541) 997-7121.
BLACK DRAGON RESOURCE COMPANIES (OTC: BDGR)
"Up 95.24% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/BDGR.php
Black Dragon Resource Companies, Inc. engages in the acquisition, development, production, and sale of oil and gas, and natural gas properties in the United States. It produces oil and natural gas from marginal stripper wells, whose production has slowed to 1/2 barrels of crude oil per day or less. The company was incorporated in 1996 as Vita Health, Inc. and changed its name to Vita Warehouse Company, Inc. in 1999. Further, it changed its name to Texas Diversified Distributors, Inc. in 2001; to Black Dragon Resource, Inc. in February 2004; and to Black Dragon Resource Companies, Inc. in December 2004. Black Dragon Resource Companies, Inc. is headquartered in Oil City, Louisiana.
BDGR News:
January 3 - Black Dragon Announces Significant Further Progress on the Joint Venture Funding Negotiations
On January 2, 2008, Mr. Joe Lanza, President of Black Dragon Resource Companies, Inc. (OTC: BDGR) announced that negotiations with a Joint Venture Funding Partner, as previously announced last week, were close to being completed.
Mr. Lanza reiterated that the Funding Joint Partner has agreed to provide the Joint Venture with a significant investment of at least $100,000,000. He added that the Joint Venture Partner had just confirmed to its satisfaction that the Company's oil and gas reserves have a value of at least $2.7 billion dollars and that it was prepared to move forward with the transaction, subject to finalization of its audit, which should be completed within a week.
Mr. Lanza also reported that the Joint Venture Partner and the Company had agreed in principle to all terms of the Joint Venture Agreement, the completion of which is now subject only to Counsel's review.
Further, and perhaps most significant, Mr. Lanza reported that he had met with the proposed new management team who, according to Mr. Lanza, has the extensive experience in both oil and gas technology and in production management to ensure the success of the Joint Venture and the full and proper development of Black Dragon's extensive resources.
Mr. Lanza concluded by stating that he was most impressed with the proposed management team and upon the Funding of the Joint Venture and the finalization of all details of the Joint Venture that he believed his goal for the Company would have been realized and that he would promptly resign. All Black Dragon shareholders, he concluded, will be greatly benefited by the new Joint Venture structure, and with the expansion of Black Dragon operations, which could only increase shareholder value.
Management believes that all details of the Joint Venture will be finalized prior to the Annual Meeting on January 16, 2008, so that the matter could be considered by the Stockholders at that time.
MILLENNIUM CELL INCORPORATED (NASD: MCEL)
"Up 30.11% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/MCEL.php
Millennium Cell, Inc. develops hydrogen batteries for use primarily in portable electronic devices for the military, medical, industrial, and consumer markets. The hydrogen batteries comprise a fuel cell and hydrogen fuel cartridge technology. The fuel blends used in the hydrogen battery technology are comprised of a combination of water, sodium borohydride, and other chemicals. The hydrogen produced by its hydrogen fuel cartridge technology is converted into electricity by a fuel cell. The company develops the technology in partnership with corporate and government entities. It also licenses its fuel cartridge technology to fuel cell manufacturers, original equipment manufacturers, and other product-focused entities. The company has a strategic relationship with The Dow Chemical Company to collaborate on the design, development, and commercialization of proton exchange membrane fuel cell power systems and compatible Hydrogen on Demand fuel cartridges for use in portable electronic devices; and with Horizon Fuel Cell Technologies Pte, Ltd. focused on the commercialization of fuel cell based power products. Millennium Cell was founded in 1998 and is based in Eatontown, New Jersey.
MCEL News:
January 3 - Millennium Cell and Horizon Fuel Cell Provide Detailed Plans for HydroPak(TM) Portable Power Product
Latest Version to be Shown at CES and Tactical Power Source Conferences in January 2008
Major OEMs, Retailers and Distributors to Receive Samples in February
UL Certification Process Initiated, Customer Shipments Targeted for Q3
Millennium Cell Inc. (NASD: MCEL) and Horizon Fuel Cell Technologies announced the completion of a pre-production version of the HydroPak™ portable power generator that incorporates a unique water-activated cartridge system. The HydroPak™ product combines Horizon’s fuel cells with Millennium Cell’s Hydrogen on Demand® storage technology to offer a clean and quiet power generator for use by consumers and professionals for emergency and recreational purposes.
This power source is a high energy alternative to lead acid battery packs and portable generators. The HydroPak™ system, together with each cartridge:
Provides infinite shelf life and enough energy to recharge an average notebook computer 8 to 10 times.
Can run indoors with quiet operation and zero harmful emissions.
Is quieter, lighter and smaller than generators.
Stores more energy than possible with batteries.
Has a lower cost than any similar fuel cell device.
The HydroPak™ will debut at the Consumer Electronics Show (CES) at the Las Vegas Convention Center in South 1, Booth #21850H from Jan. 7-10. The system will also be shown to the U.S. military at the Tactical Power Sources Summit 2008 at the Georgetown University Conference Center in Washington, D.C. on Jan. 29-30. These conferences are the first venues where potential users and distributors can see HydroPak™ emergency power products publicly in the United States.
The HydroPak™ is designed with a common AC outlet and two USB connectors to charge or operate low power devices such as portable lights, notebook computers, portable televisions and ad hoc communications networks for more than 14 continuous hours when needed. The planned retail pricing of $400 for the system and $20 for the disposable cartridges will make this solution attractive to both professionals responding to emergencies, as well as consumers desiring power for both backup and recreational needs.
Beginning in February 2008, Horizon and Millennium Cell plan to demonstrate and sample limited numbers of the current pre-production unit to OEM’s, distributors, and key military decision makers. The current design of the unit is in the process of evaluation by Underwriters Laboratories (UL) and it is expected that listing will be received by mid 2008 on this product. Subsequently, several thousand units will be manufactured by Horizon for sale in the second half of 2008. Millennium Cell will have sole responsibility for all sales of the HydroPak™ power generation system in the United States.
Additional products have been identified for development and are expected to be shipped to commercial and government customers for evaluation in 2008 and 2009. A HydroPak Mini™ product prototype for use in consumer devices such as cell phones, PDA’s and portable media players will also be demonstrated for the first time at the conferences in January. The objective of showing this unit is to gauge interest for a less expensive, smaller power source with unlimited shelf life and silent power for smaller portable communications and electronics devices.
“We are excited about the prospects for the HydroPak™ line of products, beginning with the commercialization of the first water-activated portable power system in 2008 and followed shortly by others in 2009. We believe that these fuel cell power products possess a potent combination of convenience, performance and economics that are unique in the marketplace and will fill a void that exists today,” commented George Gu, CEO of Horizon Fuel Cell Technologies.
In October, the two companies signed a Letter of Intent (LOI) to collaboratively develop, market, and sell certain portable fuel cell power products. The partnership is aimed at launching a number of commercial and consumer products that combine Horizon’s commercial grade fuel cells with hydrogen cartridges developed by Millennium Cell. Definitive documentation that amends the August 2007 license agreement between Horizon and Millennium Cell to reflect the terms of the LOI is expected to be completed in the first quarter of 2008.
“Millennium Cell considers the HydroPak™ product line as a cornerstone in our product strategy and we are dedicating significant resources to support product introduction into the marketplace beginning in 2008. The initial reaction from OEM’s and potential distributors for this product has been very positive and we plan to generate our first commercial revenues through aggressively marketing and selling this innovative family of products,” commented Adam Briggs, President of Millennium Cell.
PHYTOMEDICAL TECHNOLOGIES (OTCBB: PYTO)
"Up 24.14% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PYTO.php
PhytoMedical Technologies, Inc., together with its wholly owned subsidiaries, operates as an early stage research-based biopharmaceutical company. It focuses on the identification, acquisition, development, and commercialization of plant-derived pharmaceutical and nutraceutical compounds targeting cachexia, obesity, and diabetes. The company develops BDC-03, a plant derived compound that has capacity to decrease the deposition of fat and lower cholesterol. Additionally, through a cooperative research and development agreement, PhytoMedical engages in synthesizing the active components of various polyphenolic compounds found in cinnamon bark and characterizing their beneficial health effects in cell cultures systems, animals, and humans. The company, formerly known as Enterprise Technologies, Inc., was founded in 1986 and changed its name to PhytoMedical Technologies, Inc. in 2004. PhytoMedical Technologies is headquartered in Princeton, New Jersey.
PYTO News:
January 3 - PhytoMedical's Anti-Cancer Compound Effective at Killing Brain Cancer Cells
Novel Class of Patented Anti-Cancer Compounds Demonstrates Significant Ability to Kill Human Glioblastoma (Brain) Cancer Cells, an Extremely Resistant and Often Fatal Strain of Cancer
PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), announced that research outcomes from ongoing in vitro studies of the Company’s sponsored anti-cancer compounds have successfully demonstrated the ability to kill a strain of human brain cancer cells which is otherwise highly-resistant to currently available drugs.
Led by Dartmouth College researcher Dr. Gordon Gribble, researchers have determined that, one of several patented “bis-intercalator” anti-cancer compounds being developed by PhytoMedical has achieved a 50% or greater cancer cell kill rate at a minimum concentration in studies of the SF-295 strain of human glioblastoma (brain) cancer cells — a significant outcome, given these brain cancer cells’ drug-resistant nature.
“The outstanding results of this human cancer cell study is an extremely important step towards finding a potential solution for treating glioblastoma, an often fatal form of cancer,” commented Greg Wujek, President, CEO of PhytoMedical Technologies, Inc. “The demonstrated cytotoxic effects of this unique patented compound on such a resistant strain of cancer has given us the confidence to move forward in our research and improve upon the concept of bis-intercalation and the promise it holds for the control of cancer.”
In important in vitro experiments, researchers tested several variations of patented bis-intercalator compounds. These compounds have the unique capability to “intercalate” or insert their anti-cancer molecules inside DNA sites of specific cancer cells, thereby preventing the ability of the cancer cells to replicate and ultimately forcing their death.
“We are very happy,” says Alla Kan Director of Dartmouth’s Technology Transfer Office, “that we found a good partner to help us bring these powerful new drugs claimed in Dartmouth College issued patent #6,187,787 to the patient as this is an ultimate goal of our office, to utilize research taking place in our laboratories for the public good.”
Among several compounds tested in vitro against an often fatal strain of human glioblastoma (brain) cells, researchers have identified a high performance compound which requires the least concentration in order to achieve a 50% or greater cancer cell kill rate. This strong activity against glioblastoma cancer cells is a significant achievement given these cells’ strong resistance to currently available anticancer drugs such as Lomustine, Carmustine, Nitrosourea, Hydroxyurea, and Procarbazine.
PhytoMedical’s Cancer Research: Killing Cancer’s DNA
PhytoMedical is developing a novel class of patented anti-cancer agents that have a ‘cytotoxic’ or poisonous affinity for cancer cells and are designed to bind more tightly to cancer cell DNA than many conventional anticancer drugs by a process called bis-intercalation or “double binding,” much like a molecular staple. Because the DNA is the blueprint of life for the cancer cell, such binding stops the replication of the DNA, which prevents the growth of the cancer cell and it dies.
DNA is present in the nucleus of every cell of all living organisms, which are constantly dividing through a process in which the DNA in the nucleus of the original cell replicates itself to be present in the nuclei of the two new (“daughter”) cells. If this replication cannot occur, the cell will die and the organism will eventually stop growing and die. Cancer is characterized by the development of abnormal cells that divide uncontrollably and have the ability to infiltrate and destroy normal body tissue.
At present, anticancer molecules designed to block the replication of DNA do so through “intercalation,” a mechanism in which the drug inserts itself between one set of adjacent base pairs of the DNA. PhytoMedical believes a more effective anticancer strategy is to design molecules (“bis-intercalators”) that can intercalate simultaneously at two DNA sites, thus further increasing the binding between the drug and the DNA of specific cancer cells in order to stop their replication and ultimately resulting in the death of the cancer cell.
ABOUT OTCPICKS.COM
OTCPicks.com is an Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Profile Research Reports authored by our financial writers. We publish a daily Newsletter to subscribers, and we publish our Daily Market Movers Digest which is sent out on the M2 Presswire several times daily highlighting hot OTC and OTCBB stocks. To feature a company on our web site or in our daily Newsletter or Market Mover’s Digest, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE: The OTCPicks.com employees are NOT Registered as an Investment Advisor in any jurisdiction whatsoever.
Release of Liability:
Through use of this website viewing or using you agree to hold OTCPicks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a representation by the publisher nor a solicitation of the purchase or sale of any securities. OTCPicks.com has not been compensated by any of the companies covered in this release. For a complete list of disclosures go to http://www.otcpicks.com/disclosure_details.php. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCPicks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCPicks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. OTCPicks.com and its affiliates are not registered investment advisors or a broker dealers. OTCPicks.com has been advised that the investments in companies profiled are considered to be high risk and use of the information provided is at the investor’s sole risk. OTCPicks.com also advises that the purchase of such high risk securities may result in the loss of some or all of the investment. Investors should not rely solely on the information presented. Rather, investors should use the information provided by the profiled companies as a starting point for doing additional independent research on the profiled companies in order to allow the investor to form his or her own opinion regarding investing in the profiled companies. Factual statements made by the profiled companies are made as of the date stated and are subject to change without notice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. OTCPicks.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through OTCPicks.com. OTCPicks.com owners may or may not hold positions in the companies that are profiled.
The information contained herein contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. Factors that could cause actual results to differ include the size and growth of the market for the company's products, the company's ability to fund its capital requirements in the near term and in the long term, pricing pressures, unforeseen and/or unexpected circumstances in happenings, pricing pressures, etc. Investing in securities is speculative and carries risk. Past performance does not guarantee future results.
Third Party Web Sites and Information:
